Class action filed against regeneron pharmaceuticals, inc. (regn) seeking recovery for investors - contact the gross law firm

New york , feb. 6, 2025 /prnewswire/ -- the gross law firm issues the following notice to shareholders of regeneron pharmaceuticals, inc. (nasdaq: regn). shareholders who purchased shares of regn during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

REGN Ratings Summary

REGN Quant Ranking